[HTML] nih.gov

[HTML][HTML] Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

S Akiyama, TG Cotter, A Sakuraba - World Journal of …, 2021 - ncbi.nlm.nih.gov
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …
被引用次数：23 相关文章

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.

S Akiyama, TG Cotter, A Sakuraba - World Journal of …, 2021 - europepmc.org
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.

S Akiyama, TG Cotter, A Sakuraba - 2021 - cabidigitallibrary.org
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

S Akiyama, TG Cotter… - World journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …

[引用][C] Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

S Akiyama, TG Cotter, A Sakuraba - World Journal of Gastroenterology, 2021 - elibrary.ru
[HTML] wjgnet.com

[HTML][HTML] Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

S Akiyama, TG Cotter, A Sakuraba - World Journal of Gastroenterology, 2021 - wjgnet.com
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

S Akiyama, TG Cotter… - World Journal of …, 2021 - utsouthwestern.elsevierpure.com
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …
[PDF] semanticscholar.org

[PDF][PDF] WJG

S Akiyama, TG Cotter… - World J Gastroenterol, 2021 - pdfs.semanticscholar.org
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …

[引用][C] Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

S Akiyama, TG Cotter, A Sakuraba - World Journal of Gastroenterology, 2021 - wjgnet.com
Figure 1 The possible immunological mechanism to explain how non-tumor necrosis factor-
targeted biologics can induce the development of hepatitis B reactivation. cccDNA …

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.

S Akiyama, TG Cotter, A Sakuraba - World Journal of …, 2021 - europepmc.org
Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …